兩家獨立企業由此誕生
生命科學與診斷 & 分析和企業服務
專注於生命科學和診斷業務的高增長型公司,推動科學家和醫療衛生專業人士的研究、發現和檢測,助力打造更健康的世界
我們專注於提供全方位的分析和企業服務解決方案,包括領先的OneSource實驗室服務,加速您的科學研究進程
The AlphaLISA® SureFire® Ultra™ total PI3 Kinase p85 assay is a sandwich immunoassay for quantitative detection of PI3 Kinase p85 (phosphorylated and non-phosphorylated) in cellular lysates using Alpha Technology. This assay is intended to be a normalization phosphorylation studies.
This kit has been pre-validated for use in combination with Pelago Bioscience’s CETSA® (Cellular Thermal Shift Assay) technology. Please note that further assay optimization will be required in order to adapt the kit to your particular cell line and experimental conditions. A valid CETSA® licence from Pelago Bioscience or a single kit agreement is required for using the CETSA® technology.
false falseFor research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
The AlphaLISA® SureFire® Ultra™ total PI3 Kinase p85 assay is a sandwich immunoassay for quantitative detection of total PI3 Kinase p85 (phosphorylated and non-phosphorylated) in cellular lysates using Alpha Technology.
Formats:
In the AlphaLISA SureFire Ultra assay, Donor beads are coated with streptavidin to capture one of the antibodies, which is biotinylated. Acceptor beads are coated with a proprietary CaptSure™ agent that immobilizes the other antibody, labeled with a CaptSure tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor beads close together, generating signal. The amount of light emission is directly proportional to the amount of protein present in the sample.
AlphaLISA SureFire Ultra kits are compatible with:
Alpha SureFire kits can be used for:
檢測點(200-50,000) | 10000 Assay Points |
---|---|
檢測目標 | P13 Kinase p85 |
檢測目標類 | Protein |
檢測技術 | Alpha |
自動化兼容 | Yes |
檢測方法 | Alpha |
實驗類型 | In vitro |
產品品牌名稱 | AlphaLISA SureFire Ultra |
運輸條件 | 藍冰 |
治療領域 | Oncology |
產品尺寸 | 10,000 Assay Points |
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater ...